UCB Canada Inc. is pleased to announce Health Canada has granted a Notice of Compliance (NOC) for PrBIMZELX® (bimekizumab injection) indicated for the treatment of adult patients with moderate to ...

Revance and Teoxane announce the FDA approval of RHA® Dynamic Volume from the Teoxane RHA® Collection for cheek augmentation and/or the correction of age-related midface contour deficiencies, in ...